Cannabis companies being allowed to deduct all expenses in calculating taxes makes reading The Investors Guide To Cannabis Stocks even more important. Reviewers say this book equips you to make money and avoid disasters. $MSOS #Marijuana $TCNNF $CURLF
https://t.co/Y2szVi4kDs
@RevNikolopoulos Only irrational exuberance or discovery cannabis really does cure cancer/obesity/diabetes/etc. would enable Trulieve to once again reach its all-time high of $53.73 reached in 2021 by 2030. The cap of $30-$34 seams reasonable for now.
After Trulieve closed at $8.71 on April 24th, I tweeted: "it is time to 'back-up-the-truck' and buy $TCNNF." Today it closed at $11.74 (up 34.8%) since my suggestion. Stay tuned! $MSOS
$TCNNF is now hovering near its 52 week intraday high of $11.83 after having traded as high as $12.25 earlier today on news of it uplisting to the NYSE. $MSOS
Currently, $TCNNF is not marginable at most major brokerage firms. Existing Trulieve shareholders, however, will likely be able to borrow against shares once they are on the NYSE & shares will be buyable on margin. $MSOS
During the past 12 months, the highest intraday trade for $TCNNF was $11.83 on 12/18/2025. That high should be exceeded as uplisting to the NYSE nears. $MSOS
Trulieve's planned uplisting to the NYSE dwarfs Robinhood's announcing it can now be traded on its platform. The rise in price of $TCNNF should have legs beyond just today. $MSOS
Yesterday, June 3, Trulieve filed SEC Form 8-K in which it stated it was deconsolidating non-medical cannabis businesses "IN ORDER TO LIST... ($TCNNF)... ON THE NYSE." Uplisting is on the way! $MSOS
The impetus for higher $CURLF $GTBIF and $TCNNF prices provided by Robinhood's 5/29 decision to start trading those MSOs has waned in the past few days. $MSOS
Reverse stock splits have tended to be viewed negatively by cannabis investors. Uplisting to major US Exchanges, however, will require many MSOs to raise share prices via reverse split just like $CURLF. $MSOS
Trulieve's proposed domestication from British Columbia to Delaware is a step on the pathway to uplisting $TCNNF. Shareholders need to strongly support this proposal. $MSOS
I am disappointed by Trulieve's recent performance, but comforted by the fact that last saturday I won the USTA National 85 Singles Hardcourt Tennis Championship in Laguna Beach, CA. solidifying my #1 ranking in the US and elevating me to #3 in the ITF World ranking. $TCNNF $MSOS
Before markets open on Thursday, May7, Trulieve is scheduled to release its Q1 financials and host a conference call. $TCNNF investors need to focus on forward guidance for EARNINGS and CASH FLOW. $MSOS
The book value of $TCNNF will increase from $5.94/sh to ~$9.42 if 280E taxes are removed retroactively, because ~$668.4 million in uncertain tax liabilities will be converted to equity. Today's close of $10.08 is, therefore, about equal to Trulieve's possible BOOK VALUE! $MSOS
Rescheduling cannabis raises the likelihood of banking & uplisting. Both would propel MSO prices higher. Allowing credit card purchases would probably provide the greatest boost for sales. $MSOS $CNBS $AYRF $CRLBF $CURLF $TCNNF $VRNO
According to GROK AI, analysts' price targets for $TCNNF range between $12 & $16, with some forecasting a high of $21. This suggests significant upside from today's Trulieve close of $9.42. GROK says analysts rate TCNNF either a BUY or STRONG BUY. $MSOS
@sammyj_19 I believe the $6.86 market cap valuation reached on 3/18/21 was an extreme valuation for Trulieve. I believe a price of $35.84 today and its accompanying $6.86 market cap would be equally extreme. Therefore, investors should not expect TCNNF to return to $53.73.
The all-time high for $TCNNF was $53.73 on 3/18/21 when it had ~127.6 million fully diluted shares outstanding. It now has ~191.3 shares outstanding, ~50% more than 5 years ago. FWIW: At ~$35.84 TCNNF would have the same market cap as at its all-time high. $MSOS